Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Feb;23(2):132-133.
doi: 10.1016/S1473-3099(22)00665-X. Epub 2022 Oct 19.

Learning and confirming in publicly funded antiviral trials

Joseph F Standing  1 , Akosua Adom Agyeman  2
Affiliations
Comment

Learning and confirming in publicly funded antiviral trials

Joseph F Standing et al. Lancet Infect Dis. 2023 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

JFS received funding for COVID-19 antiviral projects as principal investigator from the Medical Research Council (MR/W015560/1) and as co-investigator from the National Institute for Health and Care Research (PANORAMIC 135366) and LifeArc and is a member of the independent data safety and monitoring committee for the GSK sotrovimab paediatric trial (VIR-7831-5005). AAA is employed on the Medical Research Council grant MR/W015560/1.

Comment on

References

    1. Khoo SH, FitzGerald R, Saunders G, et al. Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial. Lancet Infect Dis. 2022 doi: 10.1016/S1473-3099(22)00644-2. published online Oct 19. - DOI - PMC - PubMed
    1. Sheiner LB. Learning versus confirming in clinical drug development. Clin Pharmacol Ther. 1997;61:275–291. - PubMed
    1. Maisonnasse P, Guedj J, Contreras V, et al. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Nature. 2020;585:584–587. - PubMed
    1. Gonçalves A, Bertrand J, Ke R, et al. Timing of antiviral treatment initiation is critical to reduce SARS-CoV-2 viral load. CPT Pharmacometrics Syst Pharmacol. 2020;9:509–514. - PMC - PubMed
    1. Gastine S, Pang J, Boshier FAT, et al. Systematic review and patient-level meta-analysis of SARS-CoV-2 viral dynamics to model response to antiviral therapies. Clin Pharmacol Ther. 2021;110:321–333. - PMC - PubMed

Substances